SCHEMBL31435569

SCHEMBL31435569

Cn1cc(-c2noc3c2C(=O)CCC3)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.35
PLK1 P53350 1/20 0.35
CSNK2A1 P68400 1/20 0.35
PLK3 Q9H4B4 1/20 0.35
BMPR1A P36894 1/20 0.34
ACVRL1 P37023 1/20 0.34
ACVR1 Q04771 1/20 0.34
BRD4 O60885 1/20 0.34
CREBBP Q92793 2/20 0.33
AURKA O14965 1/20 0.33
TTK P33981 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
KDM5B Q9UGL1 2/20 0.33
MAPK1 P28482 2/20 0.33
CHEK1 O14757 1/20 0.33
PAK4 O96013 1/20 0.33
RET P07949 1/20 0.33
PHKG2 P15735 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31435598 0.79 PLK1 (0.36) PLK1CSNK2A1PLK3BMPR1AACVRL1
SCHEMBL1582995 0.75 HTR7 (0.46) SMN1; SMN2ALDH1A1BRD4
SCHEMBL9024407 0.72 HTR2A (0.49) SMN1; SMN2ALDH1A1
SCHEMBL9445146 0.72 HTR2A (0.50) SMN1; SMN2ALDH1A1BRD4MAPK1
SCHEMBL31435593 0.69 PLK1 (0.41) SMN1; SMN2ALDH1A1PLK1CSNK2A1PLK3
SCHEMBL31435577 0.69 LRRK2 (0.34) CREBBPRETJAK3AXL
SCHEMBL9024716 0.69 HTR7 (0.53) SMN1; SMN2ALDH1A1
SCHEMBL31435578 0.68 DRD4 (0.44) ALDH1A1PLK1CSNK2A1PLK3BMPR1A
SCHEMBL15133282 0.67 IGF1R (0.51) ALDH1A1
SCHEMBL9024849 0.67 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661516-A Bicyclic heterocyclic compounds, preparation method and medical application thereof 华润医药研究院(深圳)有限公司 2025-03-21 CN disclosed